• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Innocan Pharma Closes Additional Insider Debenture

HERZLIYA-CALGARY – Innocan Pharma Corp. announced that it had completed the closing of an additional secured debenture with its largest shareholder, Tamar Innovest Ltd., for gross proceeds of $200,000. The financing follows the company’s earlier ...

Vireo Growth Completes Schwazze Assets Acquisition

MINNEAPOLIS – In a move that instantly reshapes the competitive map in two key Cannabis states, Vireo Growth Inc. has completed its acquisition of major assets from Schwazze, gaining control of dozens of established dispensaries ...

BLAZE Launches Herbie AI Budtender for Cannabis E-Commerce

ANAHEIM – BLAZE, an AI-powered retail technology suite specifically designed for Cannabis dispensaries, delivery services, payments, and e-commerce has introduced Herbie AI Budtender – the virtual assistant providing personalized product guidance to customers shopping online. ...

Curaleaf Extends Automatic Share Disposition Plan

STAMFORD – Curaleaf Holdings Inc. disclosed that Peter Clateman, its Chief Legal Officer, has extended an existing automatic securities disposition plan (ASDP) to handle the exercise of stock options due to expire in July 2027 ...

  • Global CBD Gummies Market Report

Cannabis Edibles and Emergency Department Visits

LOS ANGELES- The consumption of cannabis edibles has been linked to a notable increase in emergency department (ED) visits, particularly among younger populations. Unlike inhaled cannabis, edibles have a delayed onset of effects, often leading ...

Trulieve Reports Strong Fourth Quarter Performance

LOS ANGELES- Trulieve Cannabis Corp., a multi-state cannabis operator, has announced its financial results for the fourth quarter and full year ending December 31, 2024, showcasing notable growth and operational efficiency. Financial Highlights Revenue: The ...

Emerging Policies Reshape the Psychedelics Industry

LOS ANGELES- The psychedelics sector is undergoing significant transformations due to evolving regulatory policies and scientific advancements that could redefine their therapeutic applications. A notable development occurred in August 2024 when the U.S. Food and ...

Subscribe To Our Newsletter

Go to Top